Anson Funds Management LP Lixte Biotechnology Holdings, Inc. Transaction History

Anson Funds Management LP

  • $663 Million
  • Q2 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 14, 2021
SELL
$0.8 - $1.2 $45,684 - $68,527
-57,106 Closed
0 $0
Q4 2020

Feb 16, 2021
BUY
$0.72 - $58.7 $41,116 - $3.35 Million
57,106 New
57,106 $181,000

About LIXTE BIOTECHNOLOGY HOLDINGS, INC.

LIXT Quotes by TradingView
  • Ticker LIXT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 16,646,600
  • Market Cap $33.6M
  • Description
  • Lixte Biotechnology Holdings, Inc. operates as a drug discovery company that uses biomarker technology to identify enzyme targets related with serious common diseases and designs novel compounds to attack those targets. The company primarily focuses on inhibitors of protein phosphatases that are used alone and in combination with cytotoxic agent...
More about LIXT
Track This Portfolio

Track Anson Funds Management LP Portfolio

Follow Anson Funds Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Anson Funds Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Anson Funds Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email